Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toxicology and Analysis of Psychoactive Tryptamines
Sara Malaca, Alfredo Fabrizio Lo Faro, Alice Tamborra, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9279-9279
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids
Joana Krämer, Rui Kang, Laura Grimm, et al.
Chemical Reviews (2022) Vol. 122, Iss. 3, pp. 3459-3636
Open Access | Times Cited: 284
An Update on the Implications of New Psychoactive Substances in Public Health
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4869-4869
Open Access | Times Cited: 39
Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review
Gloria Daziani, Alfredo Fabrizio Lo Faro, Vincenzo Montana, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6230-6230
Open Access | Times Cited: 33
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2AReceptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 1, pp. 62-75
Open Access | Times Cited: 23
New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
Alfredo Fabrizio Lo Faro, Diletta Berardinelli, Tommaso Cassano, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 273-273
Open Access | Times Cited: 22
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2520-2520
Open Access | Times Cited: 33
Stimulant and hallucinogenic novel psychoactive substances; an update
Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1109-1123
Open Access | Times Cited: 13
How hosts and pathogens choose the strengths of defense and counterdefense: a game-theoretical view
Shalu Dwivedi, Ravindra Garde, Stefan Schuster
Frontiers in Ecology and Evolution (2025) Vol. 12
Open Access
Tryptamine based drugs
Shaun L. Greene
Comprehensive analytical chemistry (2025)
Closed Access
The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Mariarosaria Ingegneri, Erika Smeriglio, Younes Zebbiche, et al.
Toxics (2025) Vol. 13, Iss. 4, pp. 247-247
Open Access
Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain
Elaine Meade, Sarah Hehir, Neil J. Rowan, et al.
Journal of Fungi (2022) Vol. 8, Iss. 3, pp. 290-290
Open Access | Times Cited: 19
Strategies toward the Difunctionalizations of Enamide Derivatives for Synthesizing α,β-Substituted Amines
Damien Bouchet, Thomas Varlet, Géraldine Masson
Accounts of Chemical Research (2022) Vol. 55, Iss. 22, pp. 3265-3283
Open Access | Times Cited: 19
Microextraction by packed sorbent of synthetic tryptamines from urine and ion mobility spectrometry determination
María Aparici-Lozano, Sergio Armenta, Salvador Garrigues, et al.
Advances in Sample Preparation (2023) Vol. 5, pp. 100055-100055
Open Access | Times Cited: 11
A fatal case of aspiration due to consumption of the hallucinogenic tryptamine derivative dipropyltryptamine (DPT)
Merja A. Neukamm, Stefan Pollak, V. Thoma, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 240, pp. 115959-115959
Closed Access | Times Cited: 4
Metabolic profiling of 5- Methoxy-N,N-diallyltryptamine in human liver microsomes and zebrafish using LC-Orbitrap MS
Liang Meng, Yanjiao Wang, Chenhao Zhong, et al.
Journal of Chromatography B (2025) Vol. 1256, pp. 124557-124557
Closed Access
Microsampling and enantioselective liquid chromatography coupled to mass spectrometry for chiral bioanalysis of novel psychoactive substances
Michele Protti, Ina Varfaj, Andrea Carotti, et al.
Talanta (2023) Vol. 257, pp. 124332-124332
Open Access | Times Cited: 10
Spectral trends in GC-EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds
William P. Feeney, Arun S. Moorthy, Edward Sisco
Forensic Chemistry (2022) Vol. 31, pp. 100459-100459
Open Access | Times Cited: 14
Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
Dimitra Florou, Vassiliki A. Boumba
Toxicology Reports (2021) Vol. 8, pp. 1699-1720
Open Access | Times Cited: 19
The State of the Art in Post-Mortem Redistribution and Stability of New Psychoactive Substances in Fatal Cases: A Review of the Literature
Luis Manuel Menéndez-Quintanal, José Manuel Matey, Virginia Gallo González, et al.
Psychoactives (2024) Vol. 3, Iss. 4, pp. 525-610
Open Access | Times Cited: 2
α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood
Sara Malaca, Charline Bottinelli, Laurent Fanton, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 92-92
Open Access | Times Cited: 5
Women’s mood at high altitude. sexual dimorphism in hypoxic stress modulation by the tryptophan–melatonin axis
Diana Elizabeth Alcantara-Zapata, N. Lucero, N. De Gregorio, et al.
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 5
Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers
Aurora Balloni, Anastasio Tini, Emilia Prospero, et al.
Clinical Chemistry (2024) Vol. 70, Iss. 4, pp. 597-628
Closed Access | Times Cited: 1
Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine
Marianne Skov‐Skov Bergh, Inger Lise Bogen, Katharina Elisabeth Grafinger, et al.
Drug Testing and Analysis (2024)
Open Access | Times Cited: 1
Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
Nataliya S. Vorobyeva, Alena A. Kozlova
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET
Lea Wagmann, Sascha K. Manier, Markus R. Meyer
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 5, pp. 567-572
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top